A bone marrow transplant is a treatment that replaces the damaged or diseased bone marrow with healthy blood-forming stem cells. A stem cell transplant is another name for a bone marrow transplant. For patients with hematologic malignancies, hematopoietic cell transplantation (HCT) is a life-prolonging or potentially curative therapy option. These therapeutic techniques were initially limited to younger patients due to the significant transplant-related morbidity, but they are increasingly being employed in older adults. The incidence of most hematologic malignancies rises with age, and as the population ages, so does the number of prospective older HCT candidates. Allogeneic haemopoietic stem cell transplantation (HSCT) is used to treat a limited number of individuals with a variety of malignant and non-malignant blood illnesses, as well as other immune system problems.
Title : Cellular mechanisms involved in seronegative hemolysis
Donald R Branch, University of Toronto, Canada
Title : Immuno-Oncology (IO): 2023 and beyond
Stefan Gluck, Global Medical Affairs at Celgene Corporation, United States
Title : Managing bacterial eradication in disease and survival for life support systems on earth and space
A C Matin, Stanford Medical School, United States
Title : Hereditary hemolytic anemias due to red blood cell membranopathies rheological and genetic approach
Joan LLuis Vives Corrons, University of Barcelona, Spain
Title : The complete evidence that starling’s law responsible for many errors and misconceptions on fluid therapy in shock is wrong: The correct replacement is the hydrodynamic phenomenon of the porous orifice (G) tube
Ahmed N Ghanem, Mansoura University, Egypt
Title : Breaking Down Mental Health Stigmas
Thad Cummings, Thad Cummings, United States